Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Feb 28;26(1):38785.
doi: 10.31083/AP38785. eCollection 2025 Feb.

Prolactin-elevating Antipsychotics: Anti-hero or Savior?

Chong Guan Ng  1 , Benedict Francis  1
Affiliations
Editorial

Prolactin-elevating Antipsychotics: Anti-hero or Savior?

Chong Guan Ng et al. Alpha Psychiatry. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. Chong Guan Ng is serving as one of the Editorial Board members. We declare that Chong Guan Ng had no involvement in the decision of this letter and has no access to information regarding its decision. Full responsibility for the editorial process for this article was delegated to Chaomeng Liu.

References

    1. De Hert M, Peuskens J, Sabbe T, Mitchell AJ, Stubbs B, Neven P, et al. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatrica Scandinavica . 2016;133:5–22. doi: 10.1111/acps.12459. - DOI - PubMed
    1. Hope JD, Keks NA, Copolov DL. Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications? . Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists . 2023;31:205–208. doi: 10.1177/10398562231158925. - DOI - PMC - PubMed
    1. Rahman T, Sahrmann JM, Olsen MA, Nickel KB, Miller JP, Ma C, et al. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years) Journal of Clinical Psychopharmacology . 2022;42:7–16. doi: 10.1097/JCP.0000000000001513. - DOI - PMC - PubMed
    1. Taipale H, Solmi M, Lähteenvuo M, Tanskanen A, Correll CU, Tiihonen J. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland. The Lancet. Psychiatry . 2021;8:883–891. doi: 10.1016/S2215-0366(21)00241-8. - DOI - PubMed
    1. Mackin P, Waton A, Nulkar A, Watkinson HM. Prolactin and smoking status in antipsychotic-treated patients. Journal of Psychopharmacology (Oxford, England) . 2011;25:698–703. doi: 10.1177/0269881110379289. - DOI - PubMed

Publication types

LinkOut - more resources